YU17503A - Receptor oblasti (ii) edb-fibronektina - Google Patents
Receptor oblasti (ii) edb-fibronektinaInfo
- Publication number
- YU17503A YU17503A YU17503A YUP17503A YU17503A YU 17503 A YU17503 A YU 17503A YU 17503 A YU17503 A YU 17503A YU P17503 A YUP17503 A YU P17503A YU 17503 A YU17503 A YU 17503A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- receptor
- edb
- fibronectin domain
- domain
- edb fibronectin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
Abstract
Pronalazak se odnosi na jedan protein, koji se specifično vezuje za oblasti EDB-fibronektina, postupak za prikazivanje (screening) jedinjenja, koja se sama vezuju za jedan receptor oblasti EDb-fibronektina ili za oblast EDb-fibronektina, kao i primenu tog proteina.[The invention relates to a protein, which binds specifically to the EDb-fibronectin domain, a method for screening compounds which bind to a receptor in the EDb-fibronectin-domain or to the EDb-fibronectin-domain itself, in addition to the use of said protein.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10045803A DE10045803A1 (de) | 2000-09-07 | 2000-09-07 | Rezeptor der EDb Fibronektin-Domäne |
DE2001123133 DE10123133A1 (de) | 2001-05-02 | 2001-05-02 | Rezeptor der ED¶b¶-Fibronektin-Domäne (II) |
Publications (1)
Publication Number | Publication Date |
---|---|
YU17503A true YU17503A (sh) | 2006-05-25 |
Family
ID=26007070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU17503A YU17503A (sh) | 2000-09-07 | 2001-08-30 | Receptor oblasti (ii) edb-fibronektina |
Country Status (24)
Country | Link |
---|---|
US (3) | US20020197700A1 (sh) |
EP (1) | EP1381629B1 (sh) |
JP (1) | JP2004529848A (sh) |
KR (1) | KR20030045056A (sh) |
CN (1) | CN1246333C (sh) |
AT (1) | ATE407951T1 (sh) |
AU (1) | AU1218202A (sh) |
BG (1) | BG107614A (sh) |
BR (1) | BR0113737A (sh) |
CA (1) | CA2421783A1 (sh) |
DE (1) | DE50114321D1 (sh) |
EE (1) | EE200300092A (sh) |
ES (1) | ES2312478T3 (sh) |
HK (1) | HK1064683A1 (sh) |
HR (1) | HRP20030263A2 (sh) |
HU (1) | HUP0300935A3 (sh) |
IL (1) | IL154778A0 (sh) |
NO (1) | NO20031033L (sh) |
NZ (1) | NZ524342A (sh) |
PL (1) | PL364358A1 (sh) |
RU (1) | RU2280254C2 (sh) |
SK (1) | SK2882003A3 (sh) |
WO (1) | WO2002020563A2 (sh) |
YU (1) | YU17503A (sh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001062800A1 (en) | 2000-02-24 | 2001-08-30 | Eidgenössische Technische Hochschule Zürich | Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis |
US7785591B2 (en) | 2004-10-14 | 2010-08-31 | Morphosys Ag | Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies |
BRPI0520677A2 (pt) | 2005-11-09 | 2009-05-19 | Bayer Schering Pharma Ag | identificação e caracterização de anticorpos de função de bloqueio anti-ed-b-fibronectina |
EP1892248A1 (en) * | 2006-08-21 | 2008-02-27 | Eidgenössische Technische Hochschule Zürich | Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase |
KR101515243B1 (ko) | 2007-04-02 | 2015-04-24 | 필로겐 에스.피.에이. | 종양 전이암의 신생혈관과 관련된 피브리노겐의 ed―a 항원 |
US10202442B2 (en) | 2007-07-25 | 2019-02-12 | Philogen S.P.A. | Antigen associated with lung cancers and lymphomas |
RU2486198C2 (ru) * | 2007-10-30 | 2013-06-27 | Филоджен С.П.А. | Антиген, ассоциированный с ревматоидным артритом |
ATE548052T1 (de) * | 2008-01-17 | 2012-03-15 | Philogen Spa | Kombination aus einem anti-edb-fibronectin- antikörper-il-2-fusionsprotein und einem b-zellen bindenden molekül, b-zellen-vorläufern und/oder deren krebserregendem gegenspieler |
US8679488B2 (en) | 2009-08-05 | 2014-03-25 | Philogen S.P.A. | Targeting of bone marrow neovasculature |
SI2903629T1 (sl) | 2012-10-03 | 2019-09-30 | Philogen S.P.A. | Konjugat protitelesa za uporabo pri zdravljenju vnetnih črevesnih bolezni |
EP3689903A4 (en) * | 2017-09-30 | 2022-01-12 | Hefei Lifeon Pharmaceutical Co. Ltd. | FIBRONECTIN B DOMAIN BINDING PROTEIN |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4341223A (en) * | 1981-02-04 | 1982-07-27 | Lutz Lauralee A | Fluoresceable composition and method of determining fluid flow |
US4741900A (en) * | 1982-11-16 | 1988-05-03 | Cytogen Corporation | Antibody-metal ion complexes |
US5576195A (en) * | 1985-11-01 | 1996-11-19 | Xoma Corporation | Vectors with pectate lyase signal sequence |
US5243029A (en) * | 1986-04-09 | 1993-09-07 | Fred Hutchinson Cancer Research Center | Oncofetal structure of fibronectin |
US4894326A (en) * | 1986-04-09 | 1990-01-16 | Fred Hutchinson Cancer Research Center | Monoclonal antibody defining oncofetal structure of fibronectin |
EP0330506A3 (en) * | 1988-02-26 | 1990-06-20 | Dana Farber Cancer Institute | Vla proteins |
US5177015A (en) * | 1988-08-12 | 1993-01-05 | Fred Hutchinson Cancer Research Centre | Onco-developmentally regulated α-N-acetylgalactosaminyltransferase |
US5270030A (en) * | 1988-12-29 | 1993-12-14 | Bio-Technology General Corp. | Fibrin binding domain polypeptide and method of producing |
CA2065299C (en) * | 1989-08-09 | 2001-07-24 | Buck A. Rhodes | Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
US5460785A (en) * | 1989-08-09 | 1995-10-24 | Rhomed Incorporated | Direct labeling of antibodies and other protein with metal ions |
US5120830A (en) * | 1990-10-25 | 1992-06-09 | Washington University | Inhibitory peptides against α-2, β-1 mediated mg++ dependent adhesion of platelets to collagen |
US5629291A (en) * | 1992-01-31 | 1997-05-13 | La Jolla Cancer Research Foundation | Methods of modulating fibronectin extracellular matrix assembly |
EP1997894B1 (en) * | 1992-02-06 | 2011-03-30 | Novartis Vaccines and Diagnostics, Inc. | Biosynthetic binding protein for cancer marker |
US6093399A (en) * | 1992-03-05 | 2000-07-25 | Board Of Regents, The University Of Texas System | Methods and compositions for the specific coagulation of vasculature |
US5877289A (en) * | 1992-03-05 | 1999-03-02 | The Scripps Research Institute | Tissue factor compositions and ligands for the specific coagulation of vasculature |
US6749853B1 (en) * | 1992-03-05 | 2004-06-15 | Board Of Regents, The University Of Texas System | Combined methods and compositions for coagulation and tumor treatment |
US6036955A (en) * | 1992-03-05 | 2000-03-14 | The Scripps Research Institute | Kits and methods for the specific coagulation of vasculature |
US6004555A (en) * | 1992-03-05 | 1999-12-21 | Board Of Regents, The University Of Texas System | Methods for the specific coagulation of vasculature |
US5965132A (en) * | 1992-03-05 | 1999-10-12 | Board Of Regents, The University Of Texas System | Methods and compositions for targeting the vasculature of solid tumors |
US5976535A (en) * | 1992-06-09 | 1999-11-02 | Neorx Corporation | Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore |
WO1994007598A1 (en) * | 1992-09-25 | 1994-04-14 | Otsuka Pharmaceutical Factory, Inc. | Adsorbent for cellular fibronectin, separation and purification of fibronectin, and purification of blood |
JP3339724B2 (ja) * | 1992-09-29 | 2002-10-28 | 株式会社リコー | インクジェット記録方法及びその装置 |
US5491130A (en) * | 1992-11-10 | 1996-02-13 | The United States Of America As Represented By The Department Of Health And Human Services | Peptide inhibitors of fibronectin and related collagen-binding proteins |
GB9324807D0 (en) * | 1993-12-03 | 1994-01-19 | Cancer Res Campaign Tech | Tumour antibody |
US6015897A (en) * | 1993-12-07 | 2000-01-18 | Neorx Corporation | Biotinamido-n-methylglycyl-seryl-o-succinamido-benzyl dota |
US5523229A (en) * | 1994-03-22 | 1996-06-04 | Trustees Of The University Of Pennsylvania | Antibodies specific for oncofetal fibronectin |
DE4417865A1 (de) * | 1994-05-20 | 1995-11-23 | Behringwerke Ag | Kombination von Tumornekrose-induzierenden Substanzen mit Substanzen, die durch Nekrosen aktiviert werden, zur selektiven Tumortherapie |
US5648485A (en) * | 1994-10-26 | 1997-07-15 | University Of British Columbia | β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins |
DE4445065A1 (de) * | 1994-12-07 | 1996-06-13 | Diagnostikforschung Inst | Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung |
US6140470A (en) * | 1995-06-30 | 2000-10-31 | Yale University | Human monoclonal anti-tumor antibodies |
US5808146A (en) * | 1995-11-09 | 1998-09-15 | Emory University | Amino acid analogs for tumor imaging |
GB9610967D0 (en) * | 1996-05-24 | 1996-07-31 | Cambridge Antibody Tech | Specific binding members,materials and methods |
US5913884A (en) * | 1996-09-19 | 1999-06-22 | The General Hospital Corporation | Inhibition of fibrosis by photodynamic therapy |
US5842156A (en) * | 1996-11-12 | 1998-11-24 | The United States Of America As Represented By The Secretary Of The Air Force | Multirate multiresolution target tracking |
GB9722131D0 (en) * | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
US6394952B1 (en) * | 1998-02-03 | 2002-05-28 | Adeza Biomedical Corporation | Point of care diagnostic systems |
US6267722B1 (en) * | 1998-02-03 | 2001-07-31 | Adeza Biomedical Corporation | Point of care diagnostic systems |
US6296831B1 (en) * | 1998-04-10 | 2001-10-02 | Battelle Memorial Institute | Stimulus sensitive gel with radioisotope and methods of making |
US5997842A (en) * | 1998-04-13 | 1999-12-07 | Light Sciences Limited Partnership | Radionuclide excited phosphorescent material for administering PDT |
US6852318B1 (en) * | 1998-05-08 | 2005-02-08 | The Regents Of The University Of California | Methods for detecting and inhibiting angiogenesis |
US20030045681A1 (en) * | 1998-05-11 | 2003-03-06 | Anthony J. Zelano | Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
US20030176663A1 (en) * | 1998-05-11 | 2003-09-18 | Eidgenossische Technische Hochscule | Specific binding molecules for scintigraphy |
TWI259837B (en) * | 1998-05-11 | 2006-08-11 | Eidgenossische Tech Hochscule | Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
US6630570B1 (en) * | 1999-04-09 | 2003-10-07 | Insitut für Diagnostikforschung GmbH | Short-chain peptide-dye conjugates as contrast media for optical diagnosis |
US6171578B1 (en) * | 1999-04-14 | 2001-01-09 | Diatide, Inc. | Benzodiazepine derivatives for imaging thrombi |
EP1185559A2 (en) * | 1999-04-28 | 2002-03-13 | Board Of Regents, The University Of Texas System | Compositions and methods for cancer treatment by selectively inhibiting vegf |
CA2395567A1 (en) * | 2000-01-12 | 2001-07-19 | Light Sciences Corporation | Novel treatment for eye disease |
WO2001062298A2 (en) * | 2000-02-24 | 2001-08-30 | Philogen S.R.L. | Compositions and methods for treatment of angiogenesis in pathological lesions |
US6342326B1 (en) * | 2000-05-10 | 2002-01-29 | Beckman Coulter, Inc. | Synthesis and use of acyl fluorides of cyanine dyes |
EP1372736A4 (en) * | 2001-03-07 | 2004-11-17 | Mannkind Corp | PREPARATIONS AGAINST CANCER FORMATION |
WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
MXPA04006517A (es) * | 2002-01-03 | 2005-03-31 | Schering Ag | Conjugados que comprenden un anticuerpo especifico para el dominio ed-b de fibronectina y sus usos para la deteccion y tratamiento de tumores. |
AR040956A1 (es) * | 2002-07-31 | 2005-04-27 | Schering Ag | Nuevos conjugados de efectores, procedimientos para su preparacion y su uso farmaceutico |
-
2001
- 2001-08-30 JP JP2002525182A patent/JP2004529848A/ja active Pending
- 2001-08-30 YU YU17503A patent/YU17503A/sh unknown
- 2001-08-30 HU HU0300935A patent/HUP0300935A3/hu unknown
- 2001-08-30 AT AT01980305T patent/ATE407951T1/de not_active IP Right Cessation
- 2001-08-30 DE DE50114321T patent/DE50114321D1/de not_active Expired - Lifetime
- 2001-08-30 EP EP01980305A patent/EP1381629B1/de not_active Expired - Lifetime
- 2001-08-30 KR KR10-2003-7003340A patent/KR20030045056A/ko active IP Right Grant
- 2001-08-30 CA CA002421783A patent/CA2421783A1/en not_active Abandoned
- 2001-08-30 WO PCT/EP2001/010016 patent/WO2002020563A2/de active IP Right Grant
- 2001-08-30 PL PL01364358A patent/PL364358A1/xx not_active Application Discontinuation
- 2001-08-30 ES ES01980305T patent/ES2312478T3/es not_active Expired - Lifetime
- 2001-08-30 NZ NZ524342A patent/NZ524342A/en unknown
- 2001-08-30 IL IL15477801A patent/IL154778A0/xx unknown
- 2001-08-30 AU AU1218202A patent/AU1218202A/xx active Pending
- 2001-08-30 EE EEP200300092A patent/EE200300092A/xx unknown
- 2001-08-30 CN CNB018153461A patent/CN1246333C/zh not_active Expired - Fee Related
- 2001-08-30 US US09/942,117 patent/US20020197700A1/en not_active Abandoned
- 2001-08-30 BR BR0113737-9A patent/BR0113737A/pt not_active IP Right Cessation
- 2001-08-30 RU RU2003109431/13A patent/RU2280254C2/ru not_active IP Right Cessation
- 2001-08-30 SK SK288-2003A patent/SK2882003A3/sk unknown
-
2003
- 2003-03-06 BG BG107614A patent/BG107614A/bg unknown
- 2003-03-06 NO NO20031033A patent/NO20031033L/no not_active Application Discontinuation
- 2003-04-07 HR HR20030263A patent/HRP20030263A2/hr not_active Application Discontinuation
- 2003-10-02 US US10/676,049 patent/US20050089941A1/en not_active Abandoned
-
2004
- 2004-09-28 HK HK04107490A patent/HK1064683A1/xx not_active IP Right Cessation
-
2005
- 2005-04-14 US US11/105,475 patent/US20050221434A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SK2882003A3 (en) | 2003-08-05 |
CN1246333C (zh) | 2006-03-22 |
JP2004529848A (ja) | 2004-09-30 |
WO2002020563A2 (de) | 2002-03-14 |
HUP0300935A2 (hu) | 2003-12-29 |
RU2280254C2 (ru) | 2006-07-20 |
ES2312478T3 (es) | 2009-03-01 |
ATE407951T1 (de) | 2008-09-15 |
PL364358A1 (en) | 2004-12-13 |
US20050221434A1 (en) | 2005-10-06 |
RU2003109431A (ru) | 2005-01-20 |
NO20031033L (no) | 2003-05-07 |
DE50114321D1 (de) | 2008-10-23 |
US20050089941A1 (en) | 2005-04-28 |
HK1064683A1 (en) | 2005-02-04 |
EP1381629B1 (de) | 2008-09-10 |
HRP20030263A2 (en) | 2005-10-31 |
EE200300092A (et) | 2005-06-15 |
EP1381629A2 (de) | 2004-01-21 |
AU1218202A (en) | 2002-03-22 |
IL154778A0 (en) | 2003-10-31 |
NZ524342A (en) | 2005-09-30 |
NO20031033D0 (no) | 2003-03-06 |
HUP0300935A3 (en) | 2005-09-28 |
KR20030045056A (ko) | 2003-06-09 |
US20020197700A1 (en) | 2002-12-26 |
WO2002020563A3 (de) | 2003-10-09 |
CA2421783A1 (en) | 2002-03-14 |
BG107614A (bg) | 2003-12-31 |
BR0113737A (pt) | 2004-02-25 |
CN1487953A (zh) | 2004-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200100312B (en) | Composition for washing keratin materials, based on weakly ethoxylated sorbitan ester. | |
AP1718A (en) | 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors | |
WO2000002917A3 (en) | Compounds and methods for modulating cadherin-mediated functions | |
EA200601670A1 (ru) | Конъюгаты гидроксиалкилкрахмала и белка | |
HK1057363A1 (en) | Ccr5 antagonists useful for treating aids. | |
WO2001096565A3 (en) | Binding agents: chimeric ligand/receptor proteins | |
YU17503A (sh) | Receptor oblasti (ii) edb-fibronektina | |
ZA200307365B (en) | Antibodies specific for CD44V6. | |
IL144247A0 (en) | Novel odorant receptors in drosophila | |
HK1077827A1 (en) | Diazabicyclononane and-decane derivatives their use as opioid receptor ligands | |
AU2003240822A8 (en) | Antibodies that specifically bind to neurokinin b | |
WO2002039118A8 (en) | Screening methods for bone morphogenetic mimetics | |
MA27306A1 (fr) | Ligands des recepteurs de la melanocortine. | |
AU6594701A (en) | Enzymatic assays for screening anti-cancer agents | |
ATE327510T1 (de) | Verwendung von 13c-nmr zum nachweis von bindungen | |
AU2003275834A1 (en) | ANTIBODIES THAT BIND alphaE INTEGRIN | |
IL163580A0 (en) | Assay for anti-ingap antibodies | |
WO2001070684A3 (en) | Peptidomimetic ligands for cellular receptors and ion channels | |
WO2000077208A3 (en) | Gustatory receptors in drosophila | |
DK1208213T3 (da) | Fremgangsmåde til fremstilling af proteiner i værtsceller under anvendelse af chaperoniner | |
AU2003228483A1 (en) | Antibodies that specifically bind to tr2 | |
DE60143225D1 (en) | Tapp2 polypeptide | |
ZA200300314B (en) | Polymer-modified synthetic proteins. | |
IL157966A0 (en) | Antibodies specific for cd44v6 | |
TW200504218A (en) | Methods for preventing gluconoylation of proteins |